BVF »

Sab Biotherapeutics shares owned by BVF

Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by BVF from 13F filings

Historical chart of BVF investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by BVF consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by BVF

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.8M 918k 3.10
2024-03-31 $4.2M 918k 4.54

More positions owned by BVF

Moonlake Immunotherapeutics Class A Ord (MLTX)
Revolution Medicines (RVMD)
Kymera Therapeutics (KYMR)
Ionis Pharmaceuticals (IONS)
Mirum Pharmaceuticals (MIRM)
Gh Research Ordinary Shares (GHRS)
Protagonist Therapeutics (PTGX)
Cullinan Oncology (CGEM)
Olema Pharmaceuticals (OLMA)
Structure Therapeutics Sponsored Ads (GPCR)
Xoma Corp Del Com New (XOMA)
Kura Oncology (KURA)
4d Molecular Therapeutics In (FDMT)
Axsome Therapeutics (AXSM)
Cg Oncology (CGON)

View all positions for BVF

Top funds holding Sab Biotherapeutics

BVF
Marshall Wace
Sessa Capital IM
Vanguard Group
HB Wealth Management
Geode Capital Management
Millennium Management
Pathstone Holdings
First Manhattan
First PREMIER Bank
Institutional & Family Asset Management
BlackRock
Tower Research Capital
Morgan Stanley
Princeton Global Asset Management

View all funds holding Sab Biotherapeutics